Novel larvicide tablets of Bacillus thuringiensis var. israelensis: Assessment of larvicidal effect on Aedes aegypti (Diptera: Culicidae) in Colombia

Introduction: Aedes (Stegomyia) aegypti is the vector for dengue, chikungunya, and Zika arboviruses. Bti-CECIF is a bioinsecticide designed and developed in the form of a solid tablet for the control of this vector. It contains Bacillus thuringiensis var. israelensis (Bti) serotype H-14. Objective:...

Full description

Bibliographic Details
Published in:Biomédica
Main Authors: Wilber Gómez-Vargas, Kelly Valencia-Jiménez, Guillermo Correa-Londoño, Faiber Jaramillo-Yepes
Format: Article in Journal/Newspaper
Language:English
Spanish
Published: Instituto Nacional de Salud 2018
Subjects:
R
Online Access:https://doi.org/10.7705/biomedica.v38i0.3940
https://doaj.org/article/f069e6adedf5414e908bd59d1e4470de
id ftdoajarticles:oai:doaj.org/article:f069e6adedf5414e908bd59d1e4470de
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:f069e6adedf5414e908bd59d1e4470de 2023-05-15T15:09:28+02:00 Novel larvicide tablets of Bacillus thuringiensis var. israelensis: Assessment of larvicidal effect on Aedes aegypti (Diptera: Culicidae) in Colombia Wilber Gómez-Vargas Kelly Valencia-Jiménez Guillermo Correa-Londoño Faiber Jaramillo-Yepes 2018-08-01T00:00:00Z https://doi.org/10.7705/biomedica.v38i0.3940 https://doaj.org/article/f069e6adedf5414e908bd59d1e4470de EN ES eng spa Instituto Nacional de Salud https://www.revistabiomedica.org/index.php/biomedica/article/view/3940 https://doaj.org/toc/0120-4157 0120-4157 doi:10.7705/biomedica.v38i0.3940 https://doaj.org/article/f069e6adedf5414e908bd59d1e4470de Biomédica: revista del Instituto Nacional de Salud, Vol 38, Iss 0, Pp 95-105 (2018) Aedes Bacillus thuringiensis disease vectors dengue chikungunya virus Zika virus Colombia Medicine R Arctic medicine. Tropical medicine RC955-962 article 2018 ftdoajarticles https://doi.org/10.7705/biomedica.v38i0.3940 2022-12-31T00:46:56Z Introduction: Aedes (Stegomyia) aegypti is the vector for dengue, chikungunya, and Zika arboviruses. Bti-CECIF is a bioinsecticide designed and developed in the form of a solid tablet for the control of this vector. It contains Bacillus thuringiensis var. israelensis (Bti) serotype H-14. Objective: To evaluate under semi-field and field conditions the efficacy and residual activity of Bti-CECIF tablets on Aedes aegypti larvae in two Colombian municipalities. Materials and methods: We tested under semi-field conditions in plastic tanks (Rotoplast™) four different Bti doses (0.13, 0.40, 0.66 and 0.93 mg/L) in the municipality of Apartadó, department of Antioquia, to assess Bti-CECIF efficacy (percentage of reduction of larval density) and the residual activity in water tanks containing A. aegypti third-instar larvae. The efficacy and residuality of the most lethal dose were subsequently evaluated under field conditions in cement tanks in the municipality of San Carlos, department of Córdoba. Results: Under semi-field conditions, the highest tested dose exhibited the greatest residual activity (15 days) after which larval mortality was 80%. Under field conditions, the highest tested Bti-CECIF doses showed 100% mortality and exhibited a residual activity of seven days in 90% of the tanks. Conclusion: Bti-CECIF tablets effectively controlled A. aegypti larvae under field conditions for up to seven days post-treatment. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Biomédica 38 95 105
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
Spanish
topic Aedes
Bacillus thuringiensis
disease vectors
dengue
chikungunya virus
Zika virus
Colombia
Medicine
R
Arctic medicine. Tropical medicine
RC955-962
spellingShingle Aedes
Bacillus thuringiensis
disease vectors
dengue
chikungunya virus
Zika virus
Colombia
Medicine
R
Arctic medicine. Tropical medicine
RC955-962
Wilber Gómez-Vargas
Kelly Valencia-Jiménez
Guillermo Correa-Londoño
Faiber Jaramillo-Yepes
Novel larvicide tablets of Bacillus thuringiensis var. israelensis: Assessment of larvicidal effect on Aedes aegypti (Diptera: Culicidae) in Colombia
topic_facet Aedes
Bacillus thuringiensis
disease vectors
dengue
chikungunya virus
Zika virus
Colombia
Medicine
R
Arctic medicine. Tropical medicine
RC955-962
description Introduction: Aedes (Stegomyia) aegypti is the vector for dengue, chikungunya, and Zika arboviruses. Bti-CECIF is a bioinsecticide designed and developed in the form of a solid tablet for the control of this vector. It contains Bacillus thuringiensis var. israelensis (Bti) serotype H-14. Objective: To evaluate under semi-field and field conditions the efficacy and residual activity of Bti-CECIF tablets on Aedes aegypti larvae in two Colombian municipalities. Materials and methods: We tested under semi-field conditions in plastic tanks (Rotoplast™) four different Bti doses (0.13, 0.40, 0.66 and 0.93 mg/L) in the municipality of Apartadó, department of Antioquia, to assess Bti-CECIF efficacy (percentage of reduction of larval density) and the residual activity in water tanks containing A. aegypti third-instar larvae. The efficacy and residuality of the most lethal dose were subsequently evaluated under field conditions in cement tanks in the municipality of San Carlos, department of Córdoba. Results: Under semi-field conditions, the highest tested dose exhibited the greatest residual activity (15 days) after which larval mortality was 80%. Under field conditions, the highest tested Bti-CECIF doses showed 100% mortality and exhibited a residual activity of seven days in 90% of the tanks. Conclusion: Bti-CECIF tablets effectively controlled A. aegypti larvae under field conditions for up to seven days post-treatment.
format Article in Journal/Newspaper
author Wilber Gómez-Vargas
Kelly Valencia-Jiménez
Guillermo Correa-Londoño
Faiber Jaramillo-Yepes
author_facet Wilber Gómez-Vargas
Kelly Valencia-Jiménez
Guillermo Correa-Londoño
Faiber Jaramillo-Yepes
author_sort Wilber Gómez-Vargas
title Novel larvicide tablets of Bacillus thuringiensis var. israelensis: Assessment of larvicidal effect on Aedes aegypti (Diptera: Culicidae) in Colombia
title_short Novel larvicide tablets of Bacillus thuringiensis var. israelensis: Assessment of larvicidal effect on Aedes aegypti (Diptera: Culicidae) in Colombia
title_full Novel larvicide tablets of Bacillus thuringiensis var. israelensis: Assessment of larvicidal effect on Aedes aegypti (Diptera: Culicidae) in Colombia
title_fullStr Novel larvicide tablets of Bacillus thuringiensis var. israelensis: Assessment of larvicidal effect on Aedes aegypti (Diptera: Culicidae) in Colombia
title_full_unstemmed Novel larvicide tablets of Bacillus thuringiensis var. israelensis: Assessment of larvicidal effect on Aedes aegypti (Diptera: Culicidae) in Colombia
title_sort novel larvicide tablets of bacillus thuringiensis var. israelensis: assessment of larvicidal effect on aedes aegypti (diptera: culicidae) in colombia
publisher Instituto Nacional de Salud
publishDate 2018
url https://doi.org/10.7705/biomedica.v38i0.3940
https://doaj.org/article/f069e6adedf5414e908bd59d1e4470de
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_source Biomédica: revista del Instituto Nacional de Salud, Vol 38, Iss 0, Pp 95-105 (2018)
op_relation https://www.revistabiomedica.org/index.php/biomedica/article/view/3940
https://doaj.org/toc/0120-4157
0120-4157
doi:10.7705/biomedica.v38i0.3940
https://doaj.org/article/f069e6adedf5414e908bd59d1e4470de
op_doi https://doi.org/10.7705/biomedica.v38i0.3940
container_title Biomédica
container_volume 38
container_start_page 95
op_container_end_page 105
_version_ 1766340658433359872